Actively Recruiting
The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Led by Institute of HIV Research and Innovation Foundation, Thailand · Updated on 2026-04-06
140
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
CONDITIONS
Official Title
The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identified transgender women, transgender men, or non-binary persons
- Age 18 years or older
- HIV-negative
- Engaged in chemsex or substance use within past 12 months
- Able to provide informed consent
You will not qualify if you...
- Inability to communicate in Thai sufficiently to complete study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tangerine Clinic, Institute of HIV Research and Innovation
Pathum Wan, Bangkok, Thailand, 10330
Actively Recruiting
Research Team
N
Nittaya Phanuphak, MD,PhD.
CONTACT
R
Rena Janamnuaysook, MBA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here